EDESA BIOTECH, INC. Current Liabilities
EDESA BIOTECH, INC. (EDSA) had Current Liabilities of $3.91 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $3.91M.
- 2026-03-31: Liabilities, Current $2.19M.
- 2025-12-31: Liabilities, Current $756.16K.
- 2025-09-30: Liabilities, Current $1.08M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.91M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.19M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $756.16K 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $1.08M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $672.67K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $914.70K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.90M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $1.83M 10-K · filed 2025-12-12 | |
| 2024-06-30 | $2.36M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $2.15M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.99M 10-Q · filed 2024-02-09 | |
| 2023-09-30 | $1.82M 10-K · filed 2024-12-13 | |
| 2023-06-30 | $1.53M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.56M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.28M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $2.14M 10-K · filed 2023-12-15 | |
| 2022-06-30 | $5.66M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $3.34M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.75M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $1.46M 10-K · filed 2022-12-16 | |
| 2021-06-30 | $983.47K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $4.62M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $906.33K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $1.53M 10-K · filed 2021-12-28 | |
| 2020-06-30 | $983.08K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $578.94K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $704.16K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $461.63K 10-K · filed 2020-12-07 | |
| 2019-06-30 | $1.02M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $881.41K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $183.82K 10-KT · filed 2019-12-12 | $592.02K 10-Q · filed 2019-02-05 |
| 2018-09-30 | $493.38K 10-Q · filed 2019-05-08 | |
| 2018-06-30 | $414.61K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $589.79K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $574.38K 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $320.95K 10-K · filed 2018-11-30 | |
| 2017-06-30 | $425.34K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $433.38K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $602.12K 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $623.64K 10-K · filed 2017-12-01 | |
| 2016-06-30 | $839.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $616.10K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $723.67K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $2.38M 10-K · filed 2016-12-14 | |
| 2015-06-30 | $1.78M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $2.90M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $3.96M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $672.17K 10-K · filed 2015-12-14 | |
| 2014-08-31 | $1.42M 10-K · filed 2015-12-14 | |
| 2013-08-31 | $3.87M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |